Breastfeeding by Women Living With Human Immunodeficiency Virus in a Resource-Rich Setting: A Case Series of Maternal and Infant Management and Outcomes.

The reduction in human immunodeficiency virus (HIV) transmission through breastmilk with maternal combination antiretroviral therapy (cART) has led many pregnant women living with HIV and healthcare providers to question exclusive formula feeding in resource-rich settings. Here, we describe cART prophylaxis in 3 breastfed infants whose mothers had sustained virologic suppression; all 3 of these infants remained uninfected.

[1]  Ingrid A. Beck,et al.  Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum Component , 2021, Journal of acquired immune deficiency syndromes.

[2]  P. Vernazza,et al.  Is breastfeeding an equipoise option in effectively treated HIV-infected mothers in a high-income setting? , 2018, Swiss medical weekly.

[3]  D. Moodley,et al.  Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE) A Randomized, Open-Label, Clinical Trial , 2017, Journal of acquired immune deficiency syndromes.

[4]  J. Brophy,et al.  Nevirapine Pharmacokinetics and Safety in Neonates Receiving Combination Antiretroviral Therapy for Prevention of Vertical HIV Transmission , 2017, Journal of acquired immune deficiency syndromes.

[5]  N. Rollins,et al.  Postnatal HIV transmission in breastfed infants of HIV-infected women on ART: a systematic review and meta-analysis , 2017, Journal of the International AIDS Society.

[6]  Janet Malek,et al.  Should Providers Discuss Breastfeeding With Women Living With HIV in High-Income Countries? An Ethical Analysis. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  T. F. Rinke de Wit,et al.  Prevalence and dynamics of the K65R drug resistance mutation in HIV-1-infected infants exposed to maternal therapy with lamivudine, zidovudine and either nevirapine or nelfinavir in breast milk. , 2016, The Journal of antimicrobial chemotherapy.

[8]  P. Musoke,et al.  Extended pre-exposure prophylaxis with lopinavir–ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial , 2016, The Lancet.

[9]  J. Brophy,et al.  Safety of combination antiretroviral prophylaxis in high-risk HIV-exposed newborns: a retrospective review of the Canadian experience , 2016, Journal of the International AIDS Society.

[10]  M. Hudgens,et al.  Frequent nevirapine resistance in infants infected by HIV-1 via breastfeeding while on nevirapine prophylaxis , 2015, AIDS.

[11]  J. Overbaugh,et al.  The role of cell-associated virus in mother-to-child HIV transmission. , 2014, The Journal of infectious diseases.

[12]  D. Cohan,et al.  Breastfeeding and HIV-infected women in the United States: harm reduction counseling strategies. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  J. Brophy,et al.  Prevention of vertical HIV transmission and management of the HIV-exposed infant in Canada in 2014. , 2014, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[14]  P. Van de Perre,et al.  HIV-1 Reservoirs in Breast Milk and Challenges to Elimination of Breast-Feeding Transmission of HIV-1 , 2012, Science Translational Medicine.

[15]  J. Overbaugh,et al.  HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission , 2008, AIDS.

[16]  T. Ndung’u,et al.  Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. , 2005, The Journal of infectious diseases.

[17]  C. Rousseau,et al.  Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. , 2004, The Journal of infectious diseases.